A major development playing out in crude - $60 in sight?
I think it's important to look at the crude futures curve – On TradingView I have shown the difference between the continuous front month contract and August 2023 contracts (code CL1! -NYMEX: CLQ2023) – this is now eyeing inversion, having been as high as $11. 90 in October. This is a big development in the crude complex as it removes a key reason for funds/producers to hold longs for the roll down into the next contract on expiry.
What else has caused the moves on the day?
- Poor liquidity – everyone watching Ger vs JAP - obviously many market ballers are off now for US Thanksgiving
- EU price caps on Russian exports came in a $65 to $70, perhaps higher than consensus – not that Russia will comply and work with countries that apply such caps – but I guess the view is given the caps are higher, and Russia is selling crude at discounts of c.$20 p/b, that these caps won't affect Russia supply
- The DoE Weekly Inventory data showed a 3.7m drawer in crude inventories, however, the market caught onto a 3.06m build in gasoline inventories (most since July), while distillates rose by 1.72m. I always find with the inventory report the market will see what it wants to see, but on today’s report it’s the gasoline numbers that have won out
- China Covid restrictions – obviously still highly fluid but it is influential on the demand side of crude’s driver – traders seeing new mobility controls in the city of Zhengzhou and PCR testing – we watch Beijing and Shanghai as always given the record case count sweeping the country.
We gear up to the next OPEC meeting on 4 Dec, which could even more focus if price breaks $70 – we have our eyes on US payrolls then, but the OPEC meeting could drive some solid cross-asset vol.
The material provided here has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Whilst it is not subject to any prohibition on dealing ahead of the dissemination of investment research we will not seek to take any advantage before providing it to our clients.
Pepperstone doesn’t represent that the material provided here is accurate, current or complete, and therefore shouldn’t be relied upon as such. The information, whether from a third party or not, isn’t to be considered as a recommendation; or an offer to buy or sell; or the solicitation of an offer to buy or sell any security, financial product or instrument; or to participate in any particular trading strategy. It does not take into account readers’ financial situation or investment objectives. We advise any readers of this content to seek their own advice. Without the approval of Pepperstone, reproduction or redistribution of this information isn’t permitted.